OverviewChartNewsTraderScreen

HSBC TUR.WAR.OP.END. 5CV/  DE000HT01F79  /

gettex Zettex2
21/10/2024  15:36:04 Chg.- Bid15:47:24 Ask15:47:24 Underlying Strike price Expiration date Option type
0.1600EUR - -
Bid Size: 25,000		 -
Ask Size: 25,000		 CUREVAC N.V. O.N. 2.7619 - 31/12/2078 Call
GlobeNewswire 26/08 Simtra BioPharma Solutions Appoints Dr. Lidia Serina as Head of Development Sciences
TeleTrader 05/07/2022 CureVac sues BioNTech over vaccine technology
GlobeNewswire 25/03/2022 US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA...
GlobeNewswire 13/01/2022 GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration o...
GlobeNewswire 11/01/2022 GSK and Vir Biotechnology Announce United States Government Agreement to Purchase Additional Supply ...
GlobeNewswire 17/12/2021 Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early Treatme...
GlobeNewswire 11/12/2021 Annual Changes to the Nasdaq Biotechnology Index
GlobeNewswire 07/12/2021 Ondine Biomedical appoints new Board of Directors
GlobeNewswire 07/12/2021 Preclinical Studies Demonstrate Sotrovimab Retains Activity Against the Full Combination of Mutation...
GlobeNewswire 02/12/2021 Preclinical Data Demonstrate Sotrovimab Retains Activity Against Key Omicron Mutations, New SARS-CoV...
GlobeNewswire 17/11/2021 GSK and Vir Biotechnology Announce United States Government Agreements to Purchase Sotrovimab, a COV...
GlobeNewswire 12/11/2021 Primary endpoint met in COMET-TAIL Phase 3 trial evaluating intramuscular administration of sotrovim...
TeleTrader 12/10/2021 CureVac abandons COVID shot development
GlobeNewswire 28/07/2021 GSK and Vir Biotechnology Announce Joint Procurement Agreement with European Commission for COVID-19...
TeleTrader 30/06/2021 CureVac vaccine only 48% effective against COVID - final data
GlobeNewswire 21/06/2021 GSK and Vir Biotechnology Announce Continuing Progress of the COMET Clinical Development Program for...
TeleTrader 20/06/2021 EU reconsidering CureVac deal following study - report
TeleTrader 18/06/2021 WHO official: Delta variant globally dominant
TeleTrader 17/06/2021 Europe closes mixed on Fed's hawkish forecast
TeleTrader 16/06/2021 CureVac study shows COVID jab only 47% efficient
TeleTrader 02/06/2021 Germany to increase jab supply to prevent future pandemics
GlobeNewswire 27/05/2021 GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives Emergency Use Authorization from t...
GlobeNewswire 26/05/2021 Immatics Announces Changes to its Board of Directors
TeleTrader 23/05/2021 CureVac expanding output before Q2 approval - spox
GlobeNewswire 21/05/2021 CORRECTION -- EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s Sotrovimab For t...